Initiating insulin in type 2 diabetes

被引：0

作者：

Dailey, George ^{[1
]}

机构：

[1] Scripps Clin, Div Diabet & Endocrinol, La Jolla, CA 92037 USA

来源：

DRUG DEVELOPMENT RESEARCH | 2008年 / 69卷 / 03期

关键词：

insulin; T2DM; banal insulin; prandial insulin;

D O I：

10.1002/ddr.20235

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

There are a variety of oral hypoglycemic agents available for use in type 2 diabetes. Despite the increasing choices of oral agents, insulin therapy remains the most effective means to lower blood glucose and often must be used. There is some controversy as to the best approach to the initiation of insulin treatment in type 2 diabetes. The approach we favor begins with basal insulin with later addition of premeal rapid-acting insulin.

引用

页码：116 / 118

页数：3

共 50 条

[21] Medication compliance and persistency in patients with type 2 diabetes initiating exenatide or insulin glargine
Fabunmi, Rosalind
Nielsen, Loretta
Wade, Rolin L.
Quimbo, Ralph
Schroeder, Brock
Massoudi, Marjan
Misurski, Derek A.
Wintle, Matthew
DIABETES, 2008, 57 : A346 - A346
[22] Association between Mild and Severe Hypoglycemia in Patients with Type 2 Diabetes Initiating Insulin
Festa, Andreas
Duan, Ran
Fu, Haoda
DIABETES, 2015, 64 : A107 - A107
[23] Medication compliance and persistency in patients with type 2 diabetes initiating exenatide or insulin glargine
Fabunmi, R.
Nielsen, L.
Wade, R.
Quimbo, R.
Schroeder, B.
Massoudi, M.
Misurski, D.
Wintle, M.
DIABETOLOGIA, 2008, 51 : S352 - S352
[24] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
Buysman, E.
Aagren, M.
Liu, F.
Bouchard, J.
Conner, C.
VALUE IN HEALTH, 2011, 14 (07) : A481 - A481
[25] Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes
Ted Wu
Bryan Betty
Michelle Downie
Manish Khanolkar
Gary Kilov
Brandon Orr-Walker
Gordon Senator
Greg Fulcher
Diabetes Therapy, 2015, 6 : 273 - 287
[26] PRACTICAL GUIDANCE ON THE USE OF PREMIX INSULIN ANALOGUES FOR INITIATING, INTENSIFYING OR SWITCHING INSULIN REGIMENS IN TYPE 2 DIABETES
Wu, T.
Betty, B.
Downie, M.
Khanolkar, M.
Kilov, G.
Orr-Walker, B.
Philips, A.
Senator, G.
Fulcher, G.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S87 - S87
[27] Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes
Wu, Ted
Betty, Bryan
Downie, Michelle
Khanolkar, Manish
Kilov, Gary
Orr-Walker, Brandon
Senator, Gordon
Fulcher, Greg
DIABETES THERAPY, 2015, 6 (03) : 273 - 287
[28] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
Buysman, E.
Conner, C.
Liu, F.
Aagren, M.
Bouchard, J.
VALUE IN HEALTH, 2011, 14 (03) : A98 - A98
[29] A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial
Buysman, Erin K.
Conner, Christopher
Liu, Fang
Aagren, Mark
Bouchard, Jonathan
DIABETES, 2011, 60 : A628 - A628
[30] Efficacy and safety of continuing sitagliptin when initiating insulin therapy in subjects with type 2 diabetes
Roussel, R.
Duran-Garcia, S.
Zhang, Y.
Shah, S.
Darmiento, C.
Shankar, R. R.
O'Neill, E. A.
Golm, G. T.
Lam, R. L. H.
Gantz, I.
Kaufman, K. D.
Engel, S. S.
DIABETOLOGIA, 2018, 61 : S378 - S378

← 1 2 3 4 5 →